Login / Signup

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.

Filippo de BraudChristophe DoomsRebecca S HeistCeleste LebbèMartin WermkeAnas GazzahDirk SchadendorfPiotr Lukasz RutkowskiJuergen WolfPaolo Antonio AsciertoIgnacio Gil-BazoShumei KatoMaria WolodarskiMeredith A McKeanEva Muñoz CouseloMartin SebastianArmando SantoroVesselina CookeLuca ManganelliKitty WanAnil GaurJaeyeon KimGiordano CaponigroXuân-Mai CouillebaultHelen EvansCatarina D CampbellSumit BasuMichele MoschettaAdil I Daud
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
-mutant melanoma. Prophylactic strategies aimed to lower the incidence of skin-related events are under investigation.
Keyphrases
  • wild type
  • open label
  • clinical trial
  • risk factors
  • soft tissue
  • study protocol
  • phase ii
  • phase ii study
  • wound healing
  • drug induced